The New National Pharmaceutical Policy would soon be placed for consent before the Cabinet Ministers said Mr M K Azhagiri, Indian Minister of Chemicals & Fertilizers, at the conference on “Intellectual Property Rights: Challenges and Way Forward for the Pharmaceutical Industry”, organized by Confederation of Indian Industry (CII) held in Chennai (India) on December 15, 2010.

EpiCept Corporation announced that the National Cancer Institute (NCI) has initiated a phase II trial with Crolibulin (EPC2407). The trial will assess the drug's efficacy and safety in combination with cisplatin in patients with Anaplastic Thyroid Cancer (ATC). Crolibulin is a vascular disruption and apoptosis inducing agent that has demonstrated potent anti-tumour activity in both preclinical and early clinical studies.

The National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Punjab and Bristol Mayers Squibb are jointly organising an international symposium on ‘Drug Metabolism and Pharmacokinetics (DMPK)--Applications toward Drug Discovery and Development’ from February 11 to 13 at the NIPER premises.

Cadila Pharmaceuticals Ltd. (CPL) Is one of India’s most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its Corporate Office at Bhat, Ahmedabad and State-of-art manufacturing facilities at Dholka, Ankleshwar, Kadi and Jammu accredited with USFDA, MHRA, TGA, MCA, MCC & WHO certifications.

Bharat Electronics Limited (BEL) was set up at Bangalore, India, by the Government of India under the Ministry of Defence in 1954 to meet the specialised electronic needs of the Indian defence services. Over the years, it has grown into a multi-product, multi-technology, multi-unit company serving the needs of customers in diverse fields in India and abroad .

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Manipal, today, is a knowledge powerhouse and a brand name in higher education. Over five and half decades ago, one man, Dr Tonse Madhava Anantha Pai, had a vision which ensured that everything he did then, was consigned to posterity, making sure that generation after generation of students enjoy the fruits of his labour till eternity on this lateritic plateau. And the students will, forever, have one name on their lips, that of Manipal.

Zydua Wellness Ltd. (ZWL) spearheads the Zydus group's presence In the fast growing consumer healthcare market. Integrating healthcare, nutrition, wellness and cosmeceuticals, the company caters to customers who are looking at newer and more wholesome options to lead healthier lifestyles. The company Is currently listed as Asia's 200 'Best under a Bilion' company by Forbes (2010).

The vacancies are in ESI Hospital, Tirunelveli (Tamil Nadu) of the ESI Corporation. Those candidates who are willing to accept the posting any where in the state and are willing to be transferred in any part of India on promotional posts as per policy of ESIC, need apply.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

The last few years have seen us blazing new trails and setting new standards in the pharmaceutical industry. The company has a formidable position in the industry. Sound infrastructure and well-qualified human force have helped Aristo to accomplish this achievement. Amongst top 10 pharma companies in India.

St.Peter's Institute of Pharmaceutical Sciences [SPIPS] was established in the year 1995 to provide opportunity for affective learning in the field of pharmaceutical science education. SPIPS is one of the institutes established by the St. Peter's Educational Association.

The founding fathers including doyens of the University envisioned strong base in basic and applied sciences as the bedrock on which foundation of teaching and research in agriculture and related sciences and technology had to be laid. Social Sciences and Humanities were to be attuned to scientific endeavor in consonance with the ground realities of rural society through congruency assessment and feedback.

Central Sericultural Research & Training Institute (CSRTI), Mysore, the pioneer research institution in the field of sericulture, was established at Chennapattana in 1961, under the administrative control of Central Silk Board, Ministry of Textiles, Government of India for the over all development of silk industry in the country. During the course of development the Institute was shifted to Mysore the princely city in the year 1963.

The Training and Development effort at Colgate-Palmolive is a direct outcome of the Individual Development Plan and the Business need. The business critical and individual specific needs are identified every year and a training needs inventory is drawn up.

Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world.

Sun Pharma make speciality pharmaceuticals and active pharmaceutical ingredients. Sun Pharma's brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory.